160 related articles for article (PubMed ID: 38273784)
1. Valproic acid regulates the miR-155/Jarid2 axis by affecting miR-155 promoter methylation in glioma.
Wang R; Chen Y; Kuang W; Jiang W; Zeng W; Chen Y; Liu Z
Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):174-183. PubMed ID: 38273784
[TBL] [Abstract][Full Text] [Related]
2. The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ).
Kuang W; Jiang W; Chen Y; Tian Y; Liu Z
Cancer Biol Ther; 2021 Jun; 22(5-6):392-403. PubMed ID: 34251962
[TBL] [Abstract][Full Text] [Related]
3. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis.
Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X
J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501
[TBL] [Abstract][Full Text] [Related]
4. miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM).
He Z; Cheng M; Hu J; Liu L; Liu P; Chen L; Cao D; Tang J
J Transl Med; 2022 Oct; 20(1):443. PubMed ID: 36183123
[TBL] [Abstract][Full Text] [Related]
5. miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1.
Wang T; Zhang Y; Cui B; Wang M; Li Y; Gao K
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1394-1403. PubMed ID: 33200790
[TBL] [Abstract][Full Text] [Related]
6. ZFAS1 knockdown inhibits viability and enhances cisplatin cytotoxicity by up-regulating miR-432-5p in glioma cells.
Yang G; Han B; Feng T
Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):518-526. PubMed ID: 31246330
[TBL] [Abstract][Full Text] [Related]
7. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
Krell A; Wolter M; Stojcheva N; Hertler C; Liesenberg F; Zapatka M; Weller M; Malzkorn B; Reifenberger G
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis.
Lan J; Xue Y; Chen H; Zhao S; Wu Z; Fang J; Han C; Lou M
FEBS Lett; 2014 Sep; 588(18):3333-9. PubMed ID: 25080009
[TBL] [Abstract][Full Text] [Related]
9. Methylation associated miR-1246 contributes to poor prognosis in gliomas treated with temozolomide.
Wang H; Wu B; Wang J; Hu Y; Dai X; Ye L; Cheng H
Clin Neurol Neurosurg; 2021 Jan; 200():106344. PubMed ID: 33153768
[TBL] [Abstract][Full Text] [Related]
10. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
11. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
[TBL] [Abstract][Full Text] [Related]
12. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis.
Deng Y; Zhu H; Xiao L; Liu C; Meng X
Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781
[TBL] [Abstract][Full Text] [Related]
13. Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid.
Cattaneo M; Baronchelli S; Schiffer D; Mellai M; Caldera V; Saccani GJ; Dalpra L; Daga A; Orlandi R; DeBlasio P; Biunno I
J Biol Chem; 2014 Jan; 289(5):2826-38. PubMed ID: 24311781
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA Pleiotrophin promotes carcinogenesis in glioma via regulation of microRNA-122/SRY-box transcription factor 6 axis.
Chen C; Deng L; Nie DK; Jia F; Fu LS; Wan ZQ; Lan Q
Eur J Cancer Prev; 2020 Mar; 29(2):165-173. PubMed ID: 31609809
[TBL] [Abstract][Full Text] [Related]
16. Exosome-Mediated Transfer of circ-
Li G; Lan Q
Cancer Biother Radiopharm; 2023 Feb; 38(1):62-73. PubMed ID: 34762494
[No Abstract] [Full Text] [Related]
17. LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
Cheng M; Wang Q; Chen L; Zhao D; Tang J; Xu J; He Z
Hum Pathol; 2022 May; 123():59-73. PubMed ID: 35219686
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid downregulates the expression of MGMT and sensitizes temozolomide-resistant glioma cells.
Ryu CH; Yoon WS; Park KY; Kim SM; Lim JY; Woo JS; Jeong CH; Hou Y; Jeun SS
J Biomed Biotechnol; 2012; 2012():987495. PubMed ID: 22701311
[TBL] [Abstract][Full Text] [Related]
19. Valproic Acid Sensitizes Glioma Cells to Luteolin Through Induction of Apoptosis and Autophagy via Akt Signaling.
Han W; Yu F; Wang R; Guan W; Zhi F
Cell Mol Neurobiol; 2021 Nov; 41(8):1625-1634. PubMed ID: 32719967
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FAM181A-AS1 promotes gliomagenesis by sponging miR-129-5p and upregulating ZRANB2.
Jiang X; Chen D
Aging (Albany NY); 2020 Oct; 12(20):20069-20084. PubMed ID: 33080570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
